Joanna Plonka

Opole, OP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort study.

Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort study.

Journal: Kardiologia polska

Published: February 11, 2025

Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure.

Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure.

Journal: Journal of clinical medicine

Published: December 13, 2024

Combined Use of GDF-15 and NT-Pro BNP for Outcome Prediction in Patients with Acute Heart Failure.

Combined Use of GDF-15 and NT-Pro BNP for Outcome Prediction in Patients with Acute Heart Failure.

Journal: Journal of clinical medicine

Published: September 11, 2024

sαKlotho protein is a useful biomarker and a promising cardioprotective agent in acute heart failure.

sαKlotho protein is a useful biomarker and a promising cardioprotective agent in acute heart failure.

Journal: Archives of medical science : AMS

Published: April 25, 2024

Diagnostic potential of increased Klotho and FGF23 protein concentrations after myocardial infarction in patients with acute coronary syndrome.

Diagnostic potential of increased Klotho and FGF23 protein concentrations after myocardial infarction in patients with acute coronary syndrome.

Journal: Cardiology journal

Published: January 09, 2024

New-onset acute heart failure: Clinical profile and one-year outcomes. Observations from the OP-AHF Registry.

New-onset acute heart failure: Clinical profile and one-year outcomes. Observations from the OP-AHF Registry.

Journal: Kardiologia polska

Published: December 07, 2023

Percutaneous treatment of right heart endocarditis.

Percutaneous treatment of right heart endocarditis.

Journal: Kardiologia polska

Published: July 10, 2023

Impella 5.0 as a bridge to recovery in severe left ventricular dysfunction.

Impella 5.0 as a bridge to recovery in severe left ventricular dysfunction.

Journal: Kardiologia polska

Published: May 19, 2023

Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first?

Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first?

Journal: Cardiology journal

Published: August 04, 2021

Balloon aortic valvuloplasty, Impella insertion and complex coronary intervention: is this all feasible fully percutaneously via upper limb access?

Balloon aortic valvuloplasty, Impella insertion and complex coronary intervention: is this all feasible fully percutaneously via upper limb access?

Journal: Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

Published: October 27, 2020

Levosimendan in the treatment of patients with acute cardiac conditions: an expert opinion of the Association of Intensive Cardiac Care of the Polish Cardiac Society.

Levosimendan in the treatment of patients with acute cardiac conditions: an expert opinion of the Association of Intensive Cardiac Care of the Polish Cardiac Society.

Journal: Kardiologia polska

Published: August 14, 2020

Levosimendan – a valuable player in the treatment of a right-sided heart failure

Levosimendan – a valuable player in the treatment of a right-sided heart failure

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: February 04, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026